Rosenberg Matthew Hamilton Has $514,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Rosenberg Matthew Hamilton grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 878 shares of the healthcare conglomerate’s stock after acquiring an additional 31 shares during the quarter. Rosenberg Matthew Hamilton’s holdings in UnitedHealth Group were worth $514,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Tealwood Asset Management Inc. acquired a new stake in UnitedHealth Group during the 3rd quarter worth about $2,905,000. Asset Planning Services Inc. LA ADV boosted its holdings in shares of UnitedHealth Group by 1.2% during the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after buying an additional 150 shares in the last quarter. Vantage Investment Partners LLC boosted its stake in UnitedHealth Group by 42.2% during the first quarter. Vantage Investment Partners LLC now owns 152,107 shares of the healthcare conglomerate’s stock worth $75,247,000 after acquiring an additional 45,173 shares in the last quarter. Sequoia Financial Advisors LLC boosted its position in shares of UnitedHealth Group by 13.7% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after purchasing an additional 3,006 shares in the last quarter. Finally, Maryland State Retirement & Pension System raised its stake in UnitedHealth Group by 0.6% during the 1st quarter. Maryland State Retirement & Pension System now owns 72,689 shares of the healthcare conglomerate’s stock worth $35,126,000 after buying an additional 469 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the topic of several research reports. Cantor Fitzgerald upped their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Robert W. Baird raised their target price on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Argus lifted their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Bank of America cut their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Finally, Barclays reduced their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Price Performance

UNH traded up $1.79 during trading on Thursday, reaching $564.75. 356,717 shares of the company were exchanged, compared to its average volume of 3,895,572. The company’s 50-day moving average is $582.60 and its two-hundred day moving average is $540.48. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The company has a market cap of $521.50 billion, a price-to-earnings ratio of 36.72, a P/E/G ratio of 1.66 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the prior year, the company posted $6.56 EPS. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. Research analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.